- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03884686
Promote Food. Improving Food-related Quality of Life in Inflammatory Bowel Disease
Promote Food. Improving Food-related Quality of Life in Patients With Inflammatory Bowel Disease: a Feasibility Study of a Web-base Educational Intervention.
In previous studies, people with inflammatory bowel disease reported that the disease had a large impact on the psychosocial aspects of eating and drinking, and a high proportion of people felt excluded from social interactions that involved eating and drinking (for example religious, family) and there was considerable uncertainty around how eating will affect bowel function together with feelings of reduced autonomy and high levels of stress and anxiety. These patient experiences may lead to reduced food related quality of life.
This randomised control trial will examine the feasibility of using a web based intervention to improve the food related quality of life of people with inflammatory bowel disease. Fifty eligible participants will be randomised to receive either a 3-month website based intervention or usual care. The feasibility of study design, an estimate of the efficacy of the website intervention and patient experience of the intervention will be assessed after three months.
Patients will be recruited from inflammatory bowel disease outpatient clinics at Guy's and St Thomas' NHS Foundation Trust and Bart's Health NHS Trust in the United Kingdom.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The intervention. The web based intervention has been developed based on the outcomes of a previous study. The website is partially populated with several pages which contain educational material designed for patients newly diagnosed (within the last 12 months) with inflammatory bowel disease. The education material provides information related to different problems, short video clips of patients talking about their problems and ways of managing it, or a patient and health care professional consultation in relation to a particular problem, as well as question and answer fact sheets. In order to make the intervention relevant and acceptable to patients and health care professionals, both these groups were actively involved at each stage of the intervention development. During the 3 month intervention patients will have free and unlimited access to the website. Use of the website during the intervention phase will be monitored by the researcher and weekly emails will be sent to participants who do not engage in the intervention. Monthly emails will be sent to all intervention group patients to encourage engagement with the intervention.
Usual care. The patients randomised to usual care will have access to all usual care, including scheduled appointments and nurse-led telephone helpful. They will not have access to the intervention website.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Reza Razavi
- Phone Number: +442078486390
- Email: reza.razavi@kcl.ac.uk
Study Contact Backup
- Name: Kevin Whelan
- Phone Number: +442078483858
- Email: kevin.whelan@kcl.ac.uk
Study Locations
-
-
-
London, United Kingdom, SE1 9RT
- Recruiting
- Guy's and St Thomas' NHS Foundation Trust
-
Contact:
- Jennifer Boston
- Email: R&D@gstt.nhs.uk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
People diagnosed with either Crohn's disease or ulcerative colitis (collectively called inflammatory bowel disease) within the last 12 months
- Proof of diagnosis (record of diagnostic endoscopy)
- Aged 16 years and over
- People who are experiencing food-related problems as a result of their inflammatory bowel disease (90 points or below, out of possible 145 measured by food related quality of life questionnaire)
- People consuming a free oral diet
- Sufficient command of written and spoken English to understand the study documentation and procedures
- Access to internet and skills and ability to use electronic resources
Exclusion Criteria:
People diagnosed with inflammatory bowel disease for more than 12 months
- Diagnosis of indeterminate colitis
- Hospitalised, nursing home or any other form of institutionalised living
- Receiving intravenous nutrition, enteral nutrition or oral nutritional support which means that food intake is less than 50% of energy requirements (i.e. their energy from food is less than their energy intake from artificial nutritional support)
- Diagnoses of other co-morbidities that may have impact on diet e.g. diabetes mellitus, coeliac disease, food allergies (not related to inflammatory bowel disease)
- Pregnancy or less than 6 months post-partum
- Inability to give informed consent (due to reduced mental capacity)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Web-based intervention
Patients allocated to intervention arm will have unlimited free access to a web-based education resource.
|
Intervention includes fact sheets, question and answers, short videos featuring patients and/or clinicians.
|
No Intervention: Usual care
Patients allocated to usual care will receive all usual care and education opportunities.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in food-related quality of life score as measured using validated questionnaire FR-QoL-29
Time Frame: 3 months
|
Measured using validated questionnaire Food-Related Quality of Life (FR-QOL), consisting of 29 questions.
Each question is answered on a 5 point Likert scale.
The sum of which is the overall score.
The minimum score is 29 (low food related quality of life) and maximum 145 (high food related quality of life).
A score of less than 90 suggests poor food related quality of life.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in United Kingdom inflammatory bowel disease questionnaire score
Time Frame: 3 months
|
Measured using validated questionnaire the United Kingdom inflammatory bowel disease questionnaire (UK-IBDQ).
This is a global disease specific quality of life questionnaire composed of 32 questions which are scored on a 4 point scale.
Minimum score is 32 which indicates very poor quality of life and maximum score is 128 which is optimal quality of life.
|
3 months
|
Change in disease activity index as measured using validated questionnaires
Time Frame: 3 months
|
Measured using validated disease specific questionnaires Harvey Bradshaw Index (HBI) if patient has Crohn's disease.
This questionnaire contains five questions.
If the patient has ulcerative colitis the simple clinical colitis activity index (SCCAI) questionnaire will be used.
It contains six questions.
The minimum scores for both questionnaires is 0 and indicates disease is in remission.
There are no maximum values but the higher the number the greater severe the disease activity.
|
3 months
|
Change in presence of anxiety and depression score
Time Frame: 3 months
|
Measured using validated questionnaire the hospital anxiety and depression score (HADS).
The questionnaire contains 14 questions which are scored from 0 to 4. Seven questions relate to anxiety and seven relate to depression.
An anxiety or depression sub-score of 0 suggests absence of anxiety or depression and a sub-score of eight or greater suggests borderline presence of anxiety or depression.
A sub-score of 10 or more suggests presence of anxiety or depression.
|
3 months
|
Collaborators and Investigators
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRAS 241127
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
Children's National Research InstituteRecruitingProfessional Quality of LifeUnited States
-
Istituto Ortopedico RizzoliUniversity of BolognaActive, not recruitingImprove Quality of LifeItaly
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
University of South CarolinaNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingHealth Related Quality of LifeUnited States
-
PharmanexSprim Advanced Life SciencesCompletedHealth-related Quality of LifeUnited States
-
Linkoeping UniversityRecruiting
-
South Valley UniversityActive, not recruitingDeterminants of Health-related Quality of Life for Patients After Renal Lithotripsy: PNL Versus RIRSHealth Related Quality of LifeEgypt
-
Region VästmanlandUnknownHealth Related Quality of Life
Clinical Trials on Web-based education resource
-
Boston Children's HospitalAmerican Academy of Sleep MedicineRecruitingIdiopathic Hypersomnia | Narcolepsy Type 1 | Narcolepsy Type 2United States
-
Innovation Research & TrainingCompleted
-
KTO Karatay UniversityRecruiting
-
KTO Karatay UniversityEnrolling by invitationCOPD | Noninvasive VentilationTurkey
-
Siirt UniversityInonu UniversityCompletedDisability Physical | Genital InfectionTurkey
-
Near East University, TurkeyActive, not recruitingDiabetes Mellitus, Type 2Turkey
-
Weill Medical College of Cornell UniversityWithdrawnAlzheimer Disease | Alzheimer Disease, Late Onset | Memory Loss | Patient Education as TopicUnited States
-
Ankara Yildirim Beyazıt UniversityCompleted
-
Suleyman Demirel UniversityCompleted
-
Northwestern UniversityWithdrawnMedical Interns and Medical Students